We are live on ! Find out more
LJHT

Laurie J. Hall Trustee Portfolio holdings

AUM $322M
1-Year Est. Return 33.73%
This Fund
S&P 500
This Quarter Est. Return
-13.76%
1 Year Est. Return
+33.73%
3 Year Est. Return
+96.04%
5 Year Est. Return
+120.73%
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$46.3M
Cap. Flow
-$6.65M
Cap. Flow %
-3.11%
Top 10 Hldgs %
34.52%
Holding
328
New
4
Increased
14
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.01M
2
CARR icon
Carrier Global
CARR
+$374K
3
ACGL icon
Arch Capital
ACGL
+$201K
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$131K
5
DIS icon
Walt Disney
DIS
+$123K

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$1.71M
2
NVDA icon
NVIDIA
NVDA
+$849K
3
AAPL icon
Apple
AAPL
+$804K
4
PACB icon
Pacific Biosciences
PACB
+$803K
5
ABT icon
Abbott
ABT
+$758K

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 24.61%
3 Industrials 12.39%
4 Consumer Staples 9.1%
5 Communication Services 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONB icon
251
Old National Bancorp
ONB
$10.2B
$12K 0.01%
844
– –
TENB icon
252
Tenable Holdings
TENB
$3.98B
$12K 0.01%
270
– –
VIAV icon
253
Viavi Solutions
VIAV
$10B
$12K 0.01%
930
– –
BABA icon
254
Alibaba
BABA
$304B
$11K 0.01%
100
-550
-85% -$53.9K
CTSH icon
255
Cognizant
CTSH
$25.6B
$11K 0.01%
170
– –
PPLI
256
People Inc
PPLI
$3.2B
$11K 0.01%
177
– –
TEL icon
257
TE Connectivity
TEL
$62.3B
$11K 0.01%
100
– –
SREV
258
DELISTED
ServiceSource International, Inc.
SREV
$11K 0.01%
7,216
– –
CYTK icon
259
Cytokinetics
CYTK
$11B
$10K ﹤0.01%
250
– –
HXL icon
260
Hexcel
HXL
$7.79B
$10K ﹤0.01%
200
– –
IONS icon
261
Ionis Pharmaceuticals
IONS
$9.06B
$10K ﹤0.01%
270
– –
MFC icon
262
Manulife Financial
MFC
$74B
$10K ﹤0.01%
600
– –
U icon
263
Unity
U
$18B
$10K ﹤0.01%
265
– –
ITCI
264
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10K ﹤0.01%
170
– –
FARO
265
DELISTED
Faro Technologies
FARO
$9K ﹤0.01%
285
– –
M icon
266
Macy's
M
$6.61B
$9K ﹤0.01%
480
– –
MTCH icon
267
Match Group
MTCH
$8.4B
$9K ﹤0.01%
126
– –
SBGI icon
268
Sinclair Inc
SBGI
$1.07B
$9K ﹤0.01%
+460
New +$10.7K
UCTT
269
Ultra Clean Holdings
UCTT
$3.76B
$9K ﹤0.01%
300
– –
WRK
270
DELISTED
WestRock Company
WRK
$9K ﹤0.01%
225
– –
LVS icon
271
Las Vegas Sands
LVS
$29.9B
$8K ﹤0.01%
250
– –
OXY icon
272
Occidental Petroleum
OXY
$56B
$8K ﹤0.01%
134
– –
TLS icon
273
Telos
TLS
$342M
$8K ﹤0.01%
1,010
– –
CRNC icon
274
Cerence
CRNC
$408M
$7K ﹤0.01%
280
– –
ICHR icon
275
Ichor Holdings
ICHR
$2.45B
$7K ﹤0.01%
280
– –
9 10
11
12 13

Similar funds

EC
Edenbrook Capital Mt. Kisco, New York $321M AUM 79.21% 1-Year Est. Return
BEP
Bluescape Energy Partners Dallas, Texas $322M AUM 18.33% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
SAMT
Select Asset Management & Trust Mechanicsburg, Pennsylvania $320M AUM 18.83% 1-Year Est. Return
FPL
Fortress Private Ledger Raleigh, North Carolina $320M AUM 45.16% 1-Year Est. Return
SGF
Stephens Greth Foundation Dallas, Texas $320M AUM
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return

Laurie J. Hall Trustee's Q2 2022 Portfolio in Review

As of Q2 2022, Laurie J. Hall Trustee held 328 positions worth $214M, down 18% from $260M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Laurie J. Hall Trustee withdrew a net $6.65M in Q2 2022, closing 7 positions and reducing 70 holdings. Its most notable exit was Pacific Biosciences, an estimated $803K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Laurie J. Hall Trustee opened a new position in Arch Capital worth $197K.

  • Laurie J. Hall Trustee's largest Q2 2022 buy was Arch Capital: 4,326 shares worth $197K.
  • Laurie J. Hall Trustee added most to Medtronic in Q2 2022, an estimated $2.01M increase.
  • Laurie J. Hall Trustee's biggest Q2 2022 reduction was Unilever, cutting an estimated $1.71M.
  • Laurie J. Hall Trustee fully exited Pacific Biosciences in Q2 2022, selling an estimated $803K.
  • Laurie J. Hall Trustee's ten largest holdings make up 35% of its $214M portfolio in Q2 2022.
  • Laurie J. Hall Trustee opened 4 new positions and closed 7 in Q2 2022.
  • Laurie J. Hall Trustee's portfolio value fell 18% quarter-over-quarter to $214M.

Based on Laurie J. Hall Trustee's 13F filing for Q2 2022, filed 6 Jul 2022.